Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 33, 2001 - Issue 11
Submit an article Journal homepage
93
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics of Human Tick-borne Encephalitis Virus Antibody Levels after Injection with Human Tick-borne Encephalitis Immunoglobulin, Solvent/Detergent Treated, FSME-BULIN S/D in Healthy Volunteers

Nils Adner, Heinz Leibl, Oskar Enzersberger, Mimika Kirgios, Thomas Wahlberg
Pages 843-847 | Published online: 08 Jul 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Megan K Young, Shu-Kay Ng, Graeme R Nimmo & Allan W Cripps. (2018) The optimal dose of disease-specific antibodies for post-exposure prophylaxis of measles and rubella in Australia: new guidelines recommended. Expert Opinion on Drug Metabolism & Toxicology 14:7, pages 663-669.
Read now
Roman Prymula, Eva Maria Pöllabauer, Borislava G. Pavlova, Alexandra Löw-Baselli, Sandor Fritsch, Rudolf Angermayr, Alexander Geisberger, P. Noel Barrett & Hartmut J. Ehrlich. (2012) Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior. Human Vaccines & Immunotherapeutics 8:6, pages 736-742.
Read now

Articles from other publishers (20)

Motoharu Yonekawa, Tohru Watanabe, Osamu Kogawara, Chihiro Yoshii, Masako Yamaji, Masakazu Aizawa, Wilhelm Erber, Shuhei Ito, Bogdan Jug, Doris Koelch, Richard de Solom & Stephen P. Lockhart. (2024) Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older. Vaccine 42:13, pages 3180-3189.
Crossref
Joachim M. Hombach, Alan D.T. Barrett, Malin Trabold & Herwig Kollaritsch. 2023. Plotkin's Vaccines. Plotkin's Vaccines 1142 1157.e6 .
Sarah J Pugh, Jennifer C Moïsi, Michael Kundi, Isabel Santonja, Wilhelm Erber, Frederick J Angulo & Luis Jodar. (2022) Effectiveness of two doses of tick-borne encephalitis (TBE) vaccine. Journal of Travel Medicine 29:2.
Crossref
Anu Kantele, Lars Rombo, Sirkka Vene, Michael Kundi, Lars Lindquist & Elina O. Erra. (2022) Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial. Vaccine 40:9, pages 1299-1305.
Crossref
R Steffen, W Erber & HJ Schmitt. (2021) Can the booster interval for the tick-borne encephalitis (TBE) vaccine ‘FSME-IMMUN’ be prolonged? — A systematic review. Ticks and Tick-borne Diseases 12:5, pages 101779.
Crossref
Erika Garner-Spitzer, Eva-Maria Poellabauer, Angelika Wagner, Angela Guzek, Ines Zwazl, Claudia Seidl-Friedrich, Christoph J. Binder, Karin Stiasny, Michael Kundi & Ursula Wiedermann. (2020) Obesity and Sex Affect the Immune Responses to Tick-Borne Encephalitis Booster Vaccination. Frontiers in Immunology 11.
Crossref
E. Poellabauer, R. Angermayr, U. Behre, P. Zhang, L. Harper, HJ. Schmitt & W. Erber. (2019) Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults. Vaccine 37:24, pages 3241-3250.
Crossref
Galina B. Maikova, Liubov L. Chernokhaeva, Yulia V. Rogova, Liubov I. Kozlovskaya, Ivan S. Kholodilov, Victor V. Romanenko, Mariya S. Esyunina, Anna A. Ankudinova, Anna S. Kilyachina, Mikhail F. Vorovitch & Galina G. Karganova. (2018) Ability of inactivated vaccines based on far‐eastern tick‐borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients. Journal of Medical Virology 91:2, pages 190-200.
Crossref
Joachim Hombach, Alan D.T. Barrett & Herwig Kollaritsch. 2018. Plotkin's Vaccines. Plotkin's Vaccines 1080 1094.e5 .
Erika Hammarlund, Archana Thomas, Ian J. Amanna, Lindsay A. Holden, Ov D. Slayden, Byung Park, Lina Gao & Mark K. Slifka. (2017) Plasma cell survival in the absence of B cell memory. Nature Communications 8:1.
Crossref
R. Konior, J. Brzostek, E.M. Poellabauer, Q. Jiang, L. Harper & W. Erber. (2017) Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5 mL in adults. Vaccine 35:28, pages 3607-3613.
Crossref
Stefan Hopf, Erika Garner-Spitzer, Michael Hofer, Michael Kundi & Ursula Wiedermann. (2016) Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine. Vaccine 34:17, pages 2027-2034.
Crossref
P. Noel Barrett, Daniel Portsmouth & Hartmut J. Ehrlich. 2013. Vaccines. Vaccines 773 788 .
Ian J. Amanna & Mark K. Slifka. (2010) Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunological Reviews 236:1, pages 125-138.
Crossref
Eva Maria Pöllabauer, Sandor Fritsch, Borislava G. Pavlova, Alexandra Löw-Baselli, Clair Firth, Manuela Koska, Friedrich Maritsch, P. Noel Barrett & Hartmut J. Ehrlich. (2010) Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine. Vaccine 28:29, pages 4558-4565.
Crossref
Eva Maria Pöllabauer, Borislava G. Pavlova, Alexandra Löw-Baselli, Sandor Fritsch, Roman Prymula, Rudolf Angermayr, Wolfgang Draxler, Clair Firth, Jael Bosman, Barbara Valenta, Peter Harmacek, Friedrich Maritsch, P. Noel Barrett & Hartmut J. Ehrlich. (2010) Comparison of immunogenicity and safety between two paediatric TBE vaccines. Vaccine 28:29, pages 4680-4685.
Crossref
P. Noel Barrett, Stanley A. Plotkin & Hartmut J. Ehrlich. 2008. Vaccines. Vaccines 841 856 .
A. Loew-Baselli, R. Konior, B.G. Pavlova, S. Fritsch, E. Poellabauer, F. Maritsch, P. Harmacek, M. Krammer, P.N. Barrett & H.J. Ehrlich. (2006) Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN®: Results of two large phase 3 clinical studies. Vaccine 24:24, pages 5256-5263.
Crossref
G??ran G??nther & Mats Haglund. (2005) Tick-Borne Encephalopathies. CNS Drugs 19:12, pages 1009-1032.
Crossref
Goro Kuno. 2003. Advances in Virus Research Volume 61. Advances in Virus Research Volume 61 3 65 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.